食品科学 ›› 2025, Vol. 46 ›› Issue (21): 126-136.doi: 10.7506/spkx1002-6630-20250611-072

• 生物工程 • 上一篇    

体外法分析不同肠段微生物对半乳甘露聚糖的利用规律

蒋雨欣,张亭,陈亚楠,赖晨欢,勇强   

  1. (1.南京林业大学 森林食物资源挖掘与利用全国重点实验室,江苏?南京 210037;2.南京林业大学化学工程学院,江苏省林业资源高效加工利用协同创新中心,江苏?南京 210037)
  • 发布日期:2025-11-10
  • 基金资助:
    中央财政林业科技推广示范项目(Su[2023]TG11)

In Vitro Analysis of the Utilization Patterns of Galactomannan by Microbiota from Different Intestinal Segments

JIANG Yuxin, ZHANG Ting, CHEN Yanan, LAI Chenhuan, YONG Qiang   

  1. (1. State Key Laboratory for the Development and Utilization of Forest Food Resources, Nanjing Forestry University, Nanjing 210037, China; 2. Jiangsu Co-innovation Center of Efficient Processing and Utilization of Forest Resources, College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China)
  • Published:2025-11-10

摘要: 为探究不同肠段微生物对半乳甘露聚糖的利用规律,以生长猪回肠和结肠微生物为接种物,以半乳甘露聚糖为唯一碳源,进行厌氧发酵。结果表明:1)回肠和结肠微生物对半乳甘露聚糖的利用效率在发酵6~12 h后较高(P<0.05),此时发酵液pH值显著下降,短链脂肪酸、氨氮以及菌体蛋白含量显著增加(P<0.05)。相较而言,结肠微生物对半乳甘露聚糖的利用能力更强。2)乳酸和乙酸是两类微生物厌氧发酵的主要有机酸代谢产物,丙酸和丁酸是差异有机酸代谢产物。3)半乳甘露聚糖改变了回肠和结肠发酵液微生物的β多样性,导致乳酸杆菌属(Lactobacillus)相对丰度显著上调(P<0.05),大肠杆菌-志贺菌属(Escherichia-Shigella)相对丰度显著下调(P<0.05)。半乳甘露聚糖还显著上调了回肠发酵液不动杆菌属(Acinetobacter)的相对丰度(P<0.05),显著下调了结肠发酵液巨球型菌属(Megasphaera)、肠球菌属(Enterococcus)、韦荣氏球菌属(Veillonella)、梭状芽孢杆菌属(Solobacterium)和考拉杆菌属(Phascolarctobacterium)的相对丰度(P<0.05)。综上,半乳甘露聚糖具有益生元潜力,能够优化菌群结构、驱动肠道短链脂肪酸的产生,其中结肠微生物对半乳甘露聚糖的利用能力更强。

关键词: 半乳甘露聚糖;肠道微生物;体外发酵;回肠;结肠

Abstract: The aim of this study was to investigate the utilization patterns of galactomannan by microbiota from different gut segments. Anaerobic fermentation was performed utilizing the ileal and colonic microbiota from growing pigs as inoculants with galactomannan as the sole carbon source. The results showed that the utilization efficiency of galactomannan by the microbiota in the ileum and colon was higher from 6 to 12 h of fermentation (P < 0.05). During this period, the pH of the fermentation broth was significantly decreased, while the contents of short-chain fatty acids, amino nitrogen, and microbial protein were significantly increased (P < 0.05). Compared with the ileal microbiota, the colonic microbiota showed a stronger capacity to utilize galactomannan. Meanwhile, lactic acid and acetic acid were the primary organic acid metabolites produced by both microbial groups during anaerobic fermentation, and propionic acid and butyric acid were identified as differential organic acid metabolites. Furthermore, galactomannan altered the beta diversity of microbial communities in both ileal and colonic fermentation broth, leading to a significant increase in the relative abundance of Lactobacillus (P < 0.05) and a significant decrease in the relative abundance of Escherichia-Shigella (P < 0.05). Galactomannan also increased the relative abundance of Acinetobacter in the ileal fermentation broth (P < 0.05) and significantly decreased the relative abundance of Megasphaera, Enterococcus, Veillonella, Solobacterium and Phascolarctobacterium in the colonic fermentation broth (P < 0.05). In conclusion, galactomannan possesses prebiotic potential and is capable of optimizing microbial community structure and driving short-chain fatty acid production. The colonic microbiota has a stronger capacity to utilize galactomannan compared with the ileal microbiota.

Key words: galactomannan; intestinal microbiota; in vitro fermentation; ileum; colon

中图分类号: